Daiwa Securities Group
PCVX icon

Daiwa Securities Group’s Vaxcyte PCVX Stock Holding History

Daiwa Securities Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$530K Sell
9,114
-230
-2% -$12.5K ﹤0.01% 957
2026
Q1 		$543K Sell
9,344
-739
-7% -$40.1K ﹤0.01% 894
2025
Q4 		$465K Buy
10,083
+369
+4% +$16.5K ﹤0.01% 893
2025
Q3 		$350K Sell
9,714
-324
-3% -$10.7K ﹤0.01% 931
2025
Q2 		$326K Buy
10,038
+6,205
+162% +$203K ﹤0.01% 913
2025
Q1 		$144K Buy
3,833
+30
+0.8% +$2.4K ﹤0.01% 958
2024
Q4 		$311K Sell
3,803
-91
-2% -$9.04K ﹤0.01% 907
2024
Q3 		$445K Hold
3,894
– – ﹤0.01% 871
2024
Q2 		$294K Sell
3,894
-4
-0.1% -$272 ﹤0.01% 921
2024
Q1 		$266K Buy
3,898
+12
+0.3% +$831 ﹤0.01% 940
2023
Q4 		$244K Buy
3,886
+3,568
+1,122% +$185K ﹤0.01% 923
2023
Q3 		$16K Hold
318
– – ﹤0.01% 1108
2023
Q2 		$16K Hold
318
– – ﹤0.01% 1116
2023
Q1 		$12K Hold
318
– – ﹤0.01% 1100
2022
Q4 		$15K Buy
318
+139
+78% +$5.46K ﹤0.01% 1092
2022
Q3 		$4K Hold
179
– – ﹤0.01% 1179
2022
Q2 		$4K Hold
179
– – ﹤0.01% 1185
2022
Q1 		$4K Hold
179
– – ﹤0.01% 1198
2021
Q4 		$4K Hold
179
– – ﹤0.01% 1224
2021
Q3 		$5K Buy
179
+83
+86% +$2.01K ﹤0.01% 1179
2021
Q2 		$2K Hold
96
– – ﹤0.01% 1149
2021
Q1 		$2K Hold
96
– – ﹤0.01% 1154
2020
Q4 		$3K Buy
+96
New +$3.57K ﹤0.01% 1094

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Daiwa Securities Group's PCVX Position: Q2 2026 in Review

Daiwa Securities Group reduced its Vaxcyte (PCVX) stake by 2.5% in Q2 2026, selling an estimated $12.5K and leaving 9,114 shares worth $530K. The position accounts for ﹤0.01% of the portfolio, ranked #957.

Daiwa Securities Group first reported a position in PCVX in Q4 2020 and has held it in 23 quarters since. The position peaked at $543K in Q1 2026. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Daiwa Securities Group held 9,114 shares of Vaxcyte worth $530K as of Q2 2026.
  • Daiwa Securities Group sold 230 Vaxcyte shares in Q2 2026, an estimated $12.5K.
  • Vaxcyte made up ﹤0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #957 holding.
  • Daiwa Securities Group first reported a position in Vaxcyte in Q4 2020 and has held it in 23 quarters since.
  • Daiwa Securities Group's Vaxcyte position peaked at $543K in Q1 2026.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.